“Non-invasive administration of poractant-α in neonatal respiratory distress syndrome via a supraglottic device in the clinical practice in a second level neonatal unit: comparison of LMA® vs iGel® devices.: Non-invasive administration of poractant-α in NRDS”, Acta Biomed, vol. 93, no. 1, p. e2022045, Mar. 2022, doi: 10.23750/abm.v93i1.11649.